MedPath

TALECRIS BIOTHERAPEUTICS INC

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

5

Active:2
Completed:1

Trial Phases

3 Phases

Phase 1:2
Phase 2:2
Not Applicable:1

Drug Approvals

8

CANADA:4

Drug Approvals

IMMUNE GLOBULIN INTRAVENOUS (HUMAN), 10%

Approval Date
Jul 31, 2000
CANADA

GAMIMUNE N 10% (IV)

Approval Date
May 16, 2000
CANADA

IMMUNE GLOBULIN INTRAVENOUS (HUMAN), 5%

Approval Date
Nov 3, 1997
CANADA

GAMIMUNE N 5% (IV)

Approval Date
Jan 17, 1997
CANADA

Clinical Trials

Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials

Phase 1
2 (40.0%)
Phase 2
2 (40.0%)
Not Applicable
1 (20.0%)
No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.